26 Scopus citations


Despite advances in neurosurgery, radiation oncology, and chemotherapy, the prognosis for glioblastoma multiforme remains poor, with a median survival time of 11-12 months. Cisplatin (cis-diamminedichlorideplatinum II) is one treatment for glioblastoma multiforme. Higher response rates have been achieved by intraarterial (i.a.) infusion than by systemic infusion of this agent. Cisplatin therapy may cause neurologic complications, and i.a. delivery has been reported to cause ocular toxicity. We report a patient who experienced intraorbital and intraocular toxicity following supraophthalmic i.a. injection of cisplatin.

Original languageEnglish (US)
Pages (from-to)195-198
Number of pages4
JournalJournal of Neuro-Ophthalmology
Issue number3
StatePublished - 1997


  • Cisplatin
  • Intra-arterial

ASJC Scopus subject areas

  • Ophthalmology
  • Clinical Neurology


Dive into the research topics of 'Ocular and orbital complications of intraarterial cisplatin: A case report'. Together they form a unique fingerprint.

Cite this